How would you manage liver-metastatic pancreatic neuroendocrine tumor after progression on a somatostatin analogue, chemotherapy, immune checkpoint blockade, and embolization?
Answer from: Medical Oncologist at Academic Institution
The optimal sequencing of systemic therapy beyond somatostatin analogs (SSAs) in patients with pancreatic NETs (pNETs) remains to be determined. Assuming that regional therapy is not feasible, there are several options such as capecitabine/temozolomide (CAPTEM), everolimus, sunitinib, and PRRT. The ...
Comments
Medical Oncologist at Alvin & Lois Lapidus Cancer Institute Northwest Hospital As you sequence through CAPTEM, PRRT, everolimus, ...
Medical Oncologist at Mayo Clinic I would typically only continue the SSA in patient...
As you sequence through CAPTEM, PRRT, everolimus, ...
I would typically only continue the SSA in patient...